These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4962524)

  • 41. [On the variability of results of sensitivity determination in tuberculosis bacteria].
    Schmiedel A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):238-47. PubMed ID: 4973009
    [No Abstract]   [Full Text] [Related]  

  • 42. [Bacteriological and clinical studies of sensitivity test (symposium)].
    Ogawa M; Osaki T; Oike Y; Kimura Z; Matsui T
    Kekkaku; 1970 Nov; 45(11):399-403. PubMed ID: 4991832
    [No Abstract]   [Full Text] [Related]  

  • 43. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents].
    Kamińska M; Czajka-Kropaczek L; Ciechanowska A
    Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657
    [No Abstract]   [Full Text] [Related]  

  • 44. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
    Bek-Lissner E; Rózewska M
    Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
    [No Abstract]   [Full Text] [Related]  

  • 45. [Frequency and clinical importance of primary pharmacoresistance of Mycobacteria in patients with tuberculosis of the lungs].
    Bibik NF
    Probl Tuberk; 1972; 50(8):20-5. PubMed ID: 4626690
    [No Abstract]   [Full Text] [Related]  

  • 46. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

  • 47. [Response of Mycobacteria tuberculosis isolated from chronic patients to single or combined drugs].
    Fanea E; Vaida T; Buzilă A; Bukşe E; Câmpeanu L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):335-42. PubMed ID: 6304848
    [No Abstract]   [Full Text] [Related]  

  • 48. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 49. [Bacillary dispersions in the lymphatic system during chronic pulmonary tuberculosis. (Histo-bacteriological studies)].
    Rossi P; Schmid G; Sternini M
    Ann Ist Carlo Forlanini; 1966; 26(4):493-507. PubMed ID: 4966441
    [No Abstract]   [Full Text] [Related]  

  • 50. [Kinetics of bacterial destruction rate as a prognostic indicator in the treatment of tuberculous patients with tuberculostatics].
    Sheri I
    Probl Tuberk; 1973; 51(11):74-8. PubMed ID: 4204394
    [No Abstract]   [Full Text] [Related]  

  • 51. [Editorial: Primary resistance to antitubercular drugs in Puerto Rico].
    Figueras ER
    Bol Asoc Med P R; 1974 Nov; 65(11):280-1. PubMed ID: 4217188
    [No Abstract]   [Full Text] [Related]  

  • 52. [Resistance and virulence of mycobacteria. Clinical and experimental studies].
    Lucchesi M
    Ftiziologia; 1971; 20(4):401-4. PubMed ID: 5005707
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on the combined activity of tuberculostatic agents on tubercle bacilli. I. Studies on the activity of thioamide of alpha-ethyl-isonicotinic acid on acid fast bacilli in vitro].
    Manowska W
    Gruzlica; 1966 Nov; 34(11):963-8. PubMed ID: 4962783
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Chemotherapy of tuberculosis].
    Kekkaku; 1974 Dec; 49(12):405-17. PubMed ID: 4218279
    [No Abstract]   [Full Text] [Related]  

  • 56. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis].
    Novozhilova IA
    Probl Tuberk Bolezn Legk; 2004; (4):29-31. PubMed ID: 15171041
    [No Abstract]   [Full Text] [Related]  

  • 57. [Comparison of laboratory and clinical antitubercular agent sensitivity tests].
    Popovic J; Praso R; Stosic Z; Davidovic C
    Plucne Bolesti Tuberk; 1971; 23(4):333-8. PubMed ID: 5004987
    [No Abstract]   [Full Text] [Related]  

  • 58. [Primary resistance of tubercle bacillus to standard drugs (incidence in Recife)].
    Magalhães M
    Rev Bras Med; 1969 Jul; 26(7):395-7. PubMed ID: 4981470
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Aspects of chemoresistance of Koch bacillus in the period 1971-1980 in the Constanţa tuberculosis outpatient clinic].
    Toldişan V; Didilescu C; Filip G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):53-7. PubMed ID: 6312536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.